Abstract:Redirecting CD8 T cell immunity with self/tumor-specific affinity-matured T cell receptors (TCRs) is a promising approach for clinical adoptive T cell therapy, with the aim to improve treatment efficacy. Despite numerous functional-based studies, little is known about the characteristics of TCR signaling (i.e., intensity, duration, and amplification) and the regulatory mechanisms underlying optimal therapeutic T cell responses. Using a panel of human SUP-T1 and primary CD8 T cells engineered with incremental affinity TCRs against the cancer-testis antigen NY-ESO-1, we found that upon activation, T cells with optimal-affinity TCRs generated intense and sustained proximal (CD3ζ, LCK) signals associated with distal (ERK1/2) amplification-gain and increased function. In contrast, in T cells with very high affinity TCRs, signal initiation was rapid and strong yet only transient, resulting in poor MAPK activation and low proliferation potential even at high antigen stimulation dose. Under resting conditions, the levels of surface TCR/CD3ε, CD8β, and CD28 expression and of CD3ζ phosphorylation were significantly reduced in those hyporesponsive cells, suggesting the presence of TCR affinity-related activation thresholds. We also show that SHP phosphatases were involved along the TCR affinity gradient, but displayed spatially distinct regulatory roles. While PTPN6/SHP-1 phosphatase activity controlled TCR signaling initiation and subsequent amplification by counteracting CD3ζ and ERK1/2 phosphorylation, PTPN11/SHP-2 augmented MAPK activation without affecting proximal TCR signaling. Together, our findings indicate that optimal TCR signaling can be finely tuned by TCR affinity-dependent SHP-1 and SHP-2 activity, and this may readily be determined at the TCR/CD3 complex level. We propose that these TCR affinity-associated regulations represent potential protective mechanisms preventing high affinity TCR-mediated autoimmune diseases.

LFA-1 nanoclusters integrate TCR stimulation strength to tune T-cell cytotoxic activity

Activation‐dependent FasL Expression in T Lymphocytes and Natural Killer Cells

Antigen-specific TCR-pMHC catch bond enables force to trigger T cell signaling

The Adaptor Protein Nck Interacts with Fas Ligand: Guiding the Death Factor to the Cytotoxic Immunological Synapse

Force-Induced Site-Specific Enzymatic Cleavage Probes Reveal That Serial Mechanical Engagement Boosts T Cell Activation

Mechano-regulation of Peptide-MHC Class I Conformations Determines TCR Antigen Recognition.

LFA-1 and CD2 Synergize for the Erk1/2 Activation in the Natural Killer (NK) Cell Immunological Synapse

Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses

What did the T cell see? A deep-learning model of CD8+ T cell activation reveals sharp antigen discrimination at the single cell level

Remote force modulation of the T-cell receptor reveals an NFAT-threshold for CD4+ T cell activation

Fine-Tuning of Optimal TCR Signaling in Tumor-Redirected CD8 T Cells by Distinct TCR Affinity-Mediated Mechanisms

LFA-1 in T Cell Migration and Differentiation

Antigen Receptor Nanoclusters: Small Units with Big Functions

Mechanistic peculiarities of activation-induced mobilization of cytotoxic effector proteins in human T cells

Engineering Mesoscale T Cell Receptor Clustering by Plug‐and‐Play Nanotools

Application of Optical Tweezers in the Research of Molecular Interaction Between Lymphocyte Function Associated Antigen-1 and Its Monoclonal Antibody

Differential Roles of Kinetic On- and Off-Rates in T-Cell Receptor Signal Integration Revealed with a Modified Fab’-DNA Ligand

Lck is Required for Activation-Induced T Cell Death after TCR Ligation with Partial Agonists

LFA-1 knockout inhibited the tumor growth and is correlated with treg cells

Effect of LFA-1 on the [Ca2+]i response in CD3-mediated activation of thymocytes